{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:32:20Z","timestamp":1787923940526,"version":"build-2784847793"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Global programs targeting 5 preventive chemotherapy neglected tropical diseases (PC-NTDs) have scaled up rapidly in recent decades due, in large part, to the generous drug donations from 6 pharmaceutical companies\u2014Eisai; Johnson &amp; Johnson (J&amp;J); GlaxoSmithKline (GSK); Merck &amp; Co., Inc., Kenilworth, New Jersey, United States of America (MSD); Merck KgaA; and Pfizer. Today, the scale of the PC-NTD drug donation programs is staggering. Nearly 15 billion tablets have been manufactured, packaged, shipped, and distributed in order to reach the people in need. The supply chains established to support such massive operations are enormously complex. Here, we describe a unique public\u2013private partnership that was formed to bring together supply chain expertise to overcome the critical challenges associated with such large-scale production and delivery of donated pharmaceutical products.<\/jats:p>","DOI":"10.1371\/journal.pntd.0008818","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:26:30Z","timestamp":1604600790000},"page":"e0008818","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["The NTD Supply Chain Forum\u2014Strengthening the backbone of NTD programs"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1971-8859","authenticated-orcid":true,"given":"Ashley A.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-0152","authenticated-orcid":true,"given":"Cassandra","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"pntd.0008818.ref001","unstructured":"WHO | World Health Organization. [cited 2020 Mar 25]. Available from: https:\/\/www.who.int\/neglected_diseases\/diseases\/en\/"},{"key":"pntd.0008818.ref002","unstructured":"Uniting to Combat Neglected Tropical Diseases. The London Declaration on Neglected Tropical Diseases. 2012 [cited 2020 Aug 18]. Available from: https:\/\/unitingtocombatntds.org\/wp-content\/uploads\/2017\/11\/london_declaration_on_ntds.pdf"},{"key":"pntd.0008818.ref003","unstructured":"MECTIZAN Donation Program\u2014MSD Responsibility. [cited 2019 Oct 22]. Available from: https:\/\/www.msdresponsibility.com\/access-to-health\/key-initiatives\/mectizan-donation-program\/"},{"key":"pntd.0008818.ref004","unstructured":"WHO | Planning, requesting medicines and reporting. [cited 2020 Mar 25]. Available from: https:\/\/www.who.int\/neglected_diseases\/preventive_chemotherapy\/reporting\/en\/"},{"key":"pntd.0008818.ref005","unstructured":"NTDeliver. [cited 2020 Sep 1]. Available from: https:\/\/www.ntdeliver.com\/report\/2019"},{"key":"pntd.0008818.ref006","unstructured":"Merck & Co., Inc.\u2014Merck Commemorates 30 Years of MECTIZAN Donation Program Progress. [cited 2019 Oct 22]. Available from: https:\/\/investors.merck.com\/news\/press-release-details\/2017\/Merck-Commemorates-30-Years-of-MECTIZAN-Donation-Program-Progress\/default.aspx"},{"key":"pntd.0008818.ref007","unstructured":"Mectizan. [cited 2019 Oct 22]. Available from: https:\/\/www.merck.com\/about\/featured-stories\/mectizan.html"},{"key":"pntd.0008818.ref008","unstructured":"mebendazole J. Initial five-year period 2012\u20132016 helminthiases in school-age children \u2022 Donated through WHO."},{"key":"pntd.0008818.ref009","unstructured":"GSK increases support for WHO strategy to improve children\u2019s health with new 5-year commitment to expand donations of albendazole medicine | GSK. [cited 2019 Oct 22]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-increases-support-for-who-strategy-to-improve-children-s-health-with-new-5-year-commitment-to-expand-donations-of-albendazole-medicine\/"},{"key":"pntd.0008818.ref010","doi-asserted-by":"crossref","first-page":"e0005402","DOI":"10.1371\/journal.pntd.0005402","article-title":"Progress and projections in the program to eliminate trachoma","volume":"11","author":"PM Emerson","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008818.ref011","unstructured":"Home | International Trachoma Initiative. [cited 2019 Oct 22]. Available from: https:\/\/www.trachoma.org\/"},{"key":"pntd.0008818.ref012","first-page":"1745","volume-title":"Health Affairs","author":"K Gustavsen","year":"2009"},{"key":"pntd.0008818.ref013","unstructured":"Johnson & Johnson Extends Long-Standing Donation Program to Support Global Effort to Tackle Intestinal Worms | Johnson & Johnson. [cited 2019 Oct 22]. Available from: https:\/\/www.jnj.com\/johnson-johnson-extends-long-standing-donation-program-to-support-global-effort-to-tackle-intestinal-worms"},{"key":"pntd.0008818.ref014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/trstmh\/trx036","article-title":"Schistosomiasis research and control since the retirement of Sir Patrick Manson in 1914","volume":"111","author":"A Fenwick","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008818.ref015","unstructured":"Schistosomiasis\u2014Company | Merck KGaA, Darmstadt, Germany. [cited 2019 Oct 22]. Available from: https:\/\/www.emdgroup.com\/en\/company\/responsibility\/our-strategy\/global-health\/schistosomiasis.html"},{"key":"pntd.0008818.ref016","unstructured":"Access to Medicines | Improving Access to Medicines | Eisai Co., Ltd. [cited 2019 Oct 22]. Available from: https:\/\/www.eisai.com\/sustainability\/atm\/medicines\/index.html"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:26:55Z","timestamp":1604600815000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008818"}},"subtitle":[],"editor":[{"given":"Simon L.","family":"Croft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008818","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}